Skip to content

Neural Therapy in Cesareans

Evaluation of the Effectiveness of Subcutaneous and Intracutaneous Local Anesthesia for Postoperative Analgesia in Patients Undergoing Cesarean Section Under General Anesthesia: a Prospective Randomized Controlled Trial (RCT)

Status
Not yet recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT06999200
Enrollment
156
Registered
2025-05-31
Start date
2025-06-10
Completion date
2025-10-10
Last updated
2025-05-31

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Visual Analogue Scale

Brief summary

In the management of pain after Caesarean section (C/S), opioid or nonsteroidal anti-inflammatory parenteral drugs are applied. These drugs are insufficient in some cases and may cause pain attacks during the day. Higher doses and repeated drug applications or combined drug administration may cause drug side effects and interactions. Alternative applications to provide analgesia include subcutaneous and intracutaneous local anesthetic application to the wound site. Although the effectiveness of these applications has been tested in individuals with different clinical characteristics and has been shown to be largely more successful, they have not been sufficiently introduced into routine practice. There is a need to review the pain methods suggested in the literature and develop new solutions that can be applied more optimally, improve the patient's pain management in the postoperative period, and increase their quality of life and satisfaction. It aims to evaluate the success of subcutaneous and intracutaneous local anesthesia applications compared to traditional applications, and to find the most optimal management.

Interventions

This prospective study will be conducted with mothers who underwent general anesthesia for labor or elective cesarean delivery and local anesthesia for postoperative pain management during a one-year period following ethical approval.

Sponsors

Haseki Training and Research Hospital
Lead SponsorOTHER

Study design

Observational model
OTHER
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
FEMALE
Age
19 Years to 45 Years
Healthy volunteers
No

Inclusion criteria

* Healthy pregnancy, * Term (\>37 weeks) and preterm (28-34 weeks) pregnancy, * Cases that received general anesthesia for cesarean section, * Cases with and without labor, * Cases with and without obesity, * Cases that had their first or second cesarean section

Exclusion criteria

* Pregnant women under 19 years of age, * Those with a history of allergic reactions to analgesics to be used, * Stillbirth, * Surgical complications during C/S and placement of an abdominal drain, * No head or breech presentation during C/S, * Occiput posterior presentation during C/S, * Anhydramnios and polyhydramnios, * Allergic reactions to the drugs used in the study, alcohol dependence, drug and substance dependence, chronic pain syndrome, neuropathic pain disorder history, * History of clinically significant cardiovascular, pulmonary, hepatic, renal, neurological, psychiatric, metabolic disease.

Design outcomes

Primary

MeasureTime frameDescription
Visual analogue scale48 hours1=no pain, 10=worst pain

Contacts

Primary Contactemine yılmaz güler
dr.emine.yilmaz@gmail.com905054525261

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026